Results For "GV20-Therapeutics"

1 News Found

GV20 Therapeutics hits milestone in AI-driven cancer therapy collaboration with Mitsubishi Tanabe Pharma

News | November 28, 2025

GV20 Therapeutics hits milestone in AI-driven cancer therapy collaboration with Mitsubishi Tanabe Pharma

GV20 received an upfront payment and is eligible for additional milestone payments

Latest Stories

Akums Drugs appoints Yuvraj Datta as President – Operational Strategy & Excellence

Apollo Pharmacy becomes 7,000-store strong

Medanta launches 550-bed super speciality hospital in Noida

White Papers

Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants

Implementing a digital transformation in chemical operations to maximize profitability

The complexity of compliance

The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation

The guiding role of fluidized and spouted bed technologies in particle building processes

Interviews

Future of manufacturing lies in mobility based manufacturing: Sandeep Rathi, Founder & CEO, Sierra Instrumentation & Controls

Future of manufacturing lies in mobility based manufacturing: Sandeep Rathi, Founder & CEO, Sierra Instrumentation & Controls

Indian companies must make their own intermediates and support small industries: Dr. K. Nagaiah, Chief Scientist, CSIR - IICT, Hyderabad

Indian companies must make their own intermediates and support small industries: Dr. K. Nagaiah, Chief Scientist, CSIR - IICT, Hyderabad

Developing basic technology for personalized medicine: Dr. Paidi Yella Reddy, Founder & CEO, Sapala Organics

Developing basic technology for personalized medicine: Dr. Paidi Yella Reddy, Founder & CEO, Sapala Organics

Packaging